Pembrolizumab in Combination with Lenvatinib as First-Line Treatment for Non Clear Cell Renal Cell Carcinoma (nccRCC), KEYNOTE-B61

Read the full video transcript Pedro Barata: Hello and welcome. My name is Pedro Barata. I…